REGN Archives — FX Audit

Regeneron Receives Emergency Use Authorization for COVID-19 Therapy

Post author:fxeditor
Post published:November 23, 2020
Post category:News
Post comments:0 Comments
Post last modified:November 23, 2020

Regeneron Pharmaceutical Inc.'s REGN-COV2 has been authorized by the U.S. drug regulators to treat early, mild to moderate COVID-19 symptoms in adults and some children of at least 12 years,…

Trump’s Administration Partners with AstraZeneca for COVID-19 Antibodies’ Manufacture

Post author:auditor
Post published:October 12, 2020
Post category:News
Post comments:0 Comments
Post last modified:October 12, 2020

Trump’s administration entered into an agreement with AstraZeneca for late-stage and large scale manufacture of AZD7442, a combination of two monoclonal antibodies that treats or prevents SARS-CoV-2, according to press…

Regeneron Receives Emergency Use Authorization for COVID-19 Therapy

Trump’s Administration Partners with AstraZeneca for COVID-19 Antibodies’ Manufacture

Reviews

Markets

Education

Company